Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
Technology
The Market Buzz
Your Environment
Analysts Are Optimistic on Johnson & Johnson’s Covid Vaccine
Johnson & Johnson (NYSE: JNJ) is actively in a phase 3 clinical trial involving 45,000 participants for its one dose Covid-19 vaccine and analysts are optimistic on the end...